Predictive Value of Amino Acids in the Treatment of Major Depression with Fluvoxamine

Publisher： Karger

E-ISSN： 1423-0224|44|3|134-138

ISSN： 0302-282x

Source： Neuropsychobiology, Vol.44, Iss.3, 2001-09, pp. : 134-138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Plasma and Platelet Amino Acid Concentrations in Patients Affected by Major Depression and under Fluvoxamine Treatment

By  

Neuropsychobiology, Vol. 37, Iss. 3, 1998-04 ,pp. : 124-129

Karger

Access to resources Recommend Favorite

Bcl1 Polymorphism of the Glucocorticoid Receptor Gene and Treatment Response to Milnacipran and Fluvoxamine in Japanese Patients with Depression

By  

Neuropsychobiology, Vol. 70, Iss. 3, 2014-10 ,pp. : 173-180

Karger

Access to resources Recommend Favorite

Clinical Features and Treatment Response of Patients with Major Depression and Silent Cerebral Infarction

By  

Neuropsychobiology, Vol. 44, Iss. 4, 2001-11 ,pp. : 176-182

Karger

Access to resources Recommend Favorite

Basal Prolactin Values Correlate with Response to Reboxetine Treatment in Major Depression, but Not with Response to Citalopram

By  

Neuropsychobiology, Vol. 51, Iss. 2, 2005-03 ,pp. : 67-71

Karger

Access to resources Recommend Favorite

Improved Alertness Is Associated with Early Increase in Serum Brain-Derived Neurotrophic Factor and Antidepressant Treatment Outcome in Major Depression

By  

Neuropsychobiology, Vol. 72, Iss. 1, 2015-0 ,pp. : 16-28

Karger

Access to resources Recommend Favorite